Characterisation of a highly potent and near pan-neutralising anti-HIV monoclonal antibody expressed in tobacco plants.

Catherine M MooreMelanie GranditsClemens Grünwald-GruberFriedrich AltmannMaria KotouckovaAudrey Y-H TehJulian K-C Ma

Published in: Retrovirology (2021)

The successful expression of N6 in tobacco supports the prospect of developing a low-cost, low-tech production platform for a monoclonal antibody cocktail to control HIV in low-to middle income countries.

Keyphrases

monoclonal antibody
low cost
antiretroviral therapy
hiv positive
hiv infected
hiv testing
human immunodeficiency virus
hepatitis c virus
hiv aids
men who have sex with men
poor prognosis
mental health
physical activity
south africa
high throughput
current status
single cell